Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Oncology
|
June 5, 2023
Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
Weili Yang, Haoran Qian, Litao Yang, et al.
FEMS Microbiology Ecology
|
October 15, 2013
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome
Shuiming Xiao, Na Fei, Xiaoyan Pang, et al.
BMC Medicine
|
May 5, 2022
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
Yue Liu, Qian Xiao, Jinjie He, et al.
Eclinicalmedicine
|
August 9, 2023
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial
Xuefeng Fang, Ning Zhu, Chenhan Zhong, et al.
Journal of Extracellular Vesicles
|
May 5, 2020
A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry
Xi Zheng, Kailun Xu, Biting Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 19, 2011
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact
Zhongtao Gai, Mifang Liang, Ying Zhang, et al.
Technology in Cancer Research & Treatment
|
February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol
Jinjie He, Yue Liu, Chengcheng Liu, et al.
Cancer Communications (London, England)
|
December 4, 2021
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
Yingkuan Shao, Kailun Xu, Xi Zheng, et al.
Pediatric Research
|
October 7, 2024
Clinical characteristics and outcomes of COVID-19 in pediatric patients with rheumatic diseases
Yating Wang, Shu Su, Mingsheng Ma, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Frontiers in Oncology
|
June 5, 2023
Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
Weili Yang, Haoran Qian, Litao Yang, et al.
FEMS Microbiology Ecology
|
October 15, 2013
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome
Shuiming Xiao, Na Fei, Xiaoyan Pang, et al.
BMC Medicine
|
May 5, 2022
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
Yue Liu, Qian Xiao, Jinjie He, et al.
Eclinicalmedicine
|
August 9, 2023
Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial
Xuefeng Fang, Ning Zhu, Chenhan Zhong, et al.
Journal of Extracellular Vesicles
|
May 5, 2020
A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry
Xi Zheng, Kailun Xu, Biting Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 19, 2011
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact
Zhongtao Gai, Mifang Liang, Ying Zhang, et al.
Technology in Cancer Research & Treatment
|
February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol
Jinjie He, Yue Liu, Chengcheng Liu, et al.
Cancer Communications (London, England)
|
December 4, 2021
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
Yingkuan Shao, Kailun Xu, Xi Zheng, et al.
Pediatric Research
|
October 7, 2024
Clinical characteristics and outcomes of COVID-19 in pediatric patients with rheumatic diseases
Yating Wang, Shu Su, Mingsheng Ma, et al.
Page
of 7